DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for BioLineRx Ltd. (BLRX)
« Back to company indexBLRX Chatter Timeline
Stock Ticker for BLRX
Most Active Tweeters for BLRX
| User | Tweets |
|---|---|
| @newsfilterio | 4 |
| @SwingTradeBot | 4 |
| @ACInvestorBlog | 4 |
| @Madeforprofit1 | 3 |
| @StckPro | 2 |
Recent Tweets for BLRX
 |
@SwingTradeBot Rose Above 50 DMA today: $BLRX $RRR ... https://t.co/qwiJH6vr1O 9:01am |
 |
@870drivenbiadre RT @Madeforprofit1: $BLRX has the PM news - could run wild https://t.co/8EeLkbSs0v 12:01am |
 |
@BlueBioNow $BLRX definitely going to finish under $2.19 -2.21 % change recently https://t.co/bVC4QXHAwm January 22nd 2020, 11:01pm |
 |
@dispatchtribune Analysts Expect BIOLINERX LTD/S $BLRX to Post -$0.64 Earnings Per Share https://t.co/8cYR2c8GNe January 22nd 2020, 9:01pm |
 |
@OlympiaReport BIOLINERX LTD/S $BLRX Expected to Post Earnings of -$0.64 Per Share https://t.co/LUc0KGxBqf January 22nd 2020, 9:01pm |
 |
@AmericanBanking Analysts Expect BIOLINERX LTD/S $BLRX to Post -$0.64 Earnings Per Share https://t.co/CXA1dyzxPU #stocks January 22nd 2020, 9:01pm |
|
@SwingTradeBot 50 DMA Support today: $APH $BLRX ... https://t.co/aW7zteKP9U January 22nd 2020, 2:01pm |
 |
@StockNewsNow $BLRX BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second… https://t.co/J8FQIf7Eav January 22nd 2020, 11:01am |
 |
@ACInvestorBlog $BLRX slowly adding today..... January 22nd 2020, 11:01am |
 |
@BioRunUp RT @BioStocks: $BLRX Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pa… January 22nd 2020, 10:01am |
 |
@Gambiste1 RT @MaisaCorp: $BLRX Completes Recruitment In Triple Combination Arm Of Combat/Keynote-202 Study January 22nd 2020, 10:01am |
 |
@MaisaCorp $BLRX Completes Recruitment In Triple Combination Arm Of Combat/Keynote-202 Study January 22nd 2020, 10:01am |
 |
@newsfilterio BioLineRx completes recruitment in triple combination arm of Combat/Keynote-202 study $BLRX https://t.co/pUsZ0WlL7b January 22nd 2020, 8:01am |
|
@newsfilterio BioLineRx completes enrollment in mid-stage BL-8040 study $BLRX https://t.co/Z93VbeJSlF January 22nd 2020, 8:01am |
 |
@MarketCurrents $BLRX - BioLineRx completes recruitment in triple combination arm of Combat/Keynote-202 study https://t.co/Fp3hM8W6te January 22nd 2020, 8:01am |
 |
@marketdollqueen RT @MDLive4: TX-News5 2020-01-22 07:01:04: $BLRX: BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in… January 22nd 2020, 8:01am |
 |
@Stock_News_Now $BLRX: New SEC Filing for BLRX: Form 6-K (No. 0001178913-20-000147): https://t.co/kp1ZrZTqsu January 22nd 2020, 8:01am |
|
@ACInvestorBlog $BLRX nice setup and news this morning. Next stop $3.05 https://t.co/4Oaoy4FtIS January 22nd 2020, 7:01am |
 |
@TekATL3 $BLRX got some news January 22nd 2020, 7:01am |
 |
@MDLive4 TX-News5 2020-01-22 07:01:04: $BLRX: BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-20… https://t.co/l3ZXaHWh7v January 22nd 2020, 7:01am |
 |
@BioStocks $BLRX Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Meta… https://t.co/3ZIMSaW750 January 22nd 2020, 7:01am |
 |
@Madeforprofit1 $BLRX has the PM news - could run wild https://t.co/8EeLkbSs0v January 22nd 2020, 7:01am |
|
@ACInvestorBlog $BLRX BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second… https://t.co/Ujy23VguAM January 22nd 2020, 7:01am |
 |
@StockTexts $BLRX BioLineRx Ltd. SEC Filing: Form 6-K https://t.co/aNxCXJsB19 January 22nd 2020, 7:01am |
 |
@StckPro $BLRX NEW ARTICLE : How To Play BioLineRx In 2020 https://t.co/CmtTtmwEKI Get all the latest $BLRX related news her… https://t.co/UTKGhvLIxA January 21st 2020, 2:01pm |
 |
@SeekingAlpha $BLRX - How To Play BioLineRx In 2020. https://t.co/2iuUE5qBwe #stockmarket #markets #investing January 21st 2020, 2:01pm |
 |
@ConsumerFeed BIOLINERX LTD/S $BLRX Downgraded to “Hold” at Zacks Investment Research https://t.co/tIvnTjmCJz January 18th 2020, 8:01am |
 |
@WeekHerald BIOLINERX LTD/S $BLRX Downgraded to “Hold” at Zacks Investment Research https://t.co/F3KHCOvZIx January 18th 2020, 8:01am |
|
@OlympiaReport BIOLINERX LTD/S $BLRX Cut to “Hold” at Zacks Investment Research https://t.co/p5cB96ErZh January 17th 2020, 7:01pm |
|
@dispatchtribune BIOLINERX LTD/S $BLRX Cut to “Hold” at Zacks Investment Research https://t.co/vFFFmDdchS January 17th 2020, 7:01pm |
 |
@Bu_LLss $BLRX possible to cross 3 next week, someone is buying https://t.co/voMmVe3eM9 January 17th 2020, 2:01pm |
|
@SwingTradeBot Fell Below 50 DMA today: $BLRX ... https://t.co/j2lcQOTpfA January 17th 2020, 11:01am |
|
@WeekHerald BIOLINERX LTD/S $BLRX Upgraded by Zacks Investment Research to “Strong-Buy” https://t.co/ObnAsS3koP January 17th 2020, 3:01am |
|
@dakotafinancial BIOLINERX LTD/S $BLRX Upgraded by Zacks Investment Research to “Strong-Buy” https://t.co/iI1ChqkOsN January 17th 2020, 3:01am |
|
@SwingTradeBot 50 DMA Resistance today: $BLRX ... https://t.co/mnYaiRq1wk January 16th 2020, 1:01pm |
 |
@TranscriptDaily Zacks Investment Research Downgrades BIOLINERX LTD/S $BLRX to Hold https://t.co/DBrtMteqAl January 16th 2020, 8:01am |
 |
@TickerReport BIOLINERX LTD/S $BLRX Stock Rating Upgraded by Zacks Investment Research https://t.co/1jqouTKoDA January 16th 2020, 4:01am |
 |
@ZolmaxNews BIOLINERX LTD/S $BLRX Lifted to Strong-Buy at Zacks Investment Research https://t.co/URytW8DNsY January 16th 2020, 4:01am |
 |
@TheMarketsDaily BIOLINERX LTD/S $BLRX Lowered to Hold at Zacks Investment Research https://t.co/gJk8wTMeDG January 15th 2020, 12:01pm |
 |
@stocknewstimes BIOLINERX LTD/S $BLRX Downgraded by Zacks Investment Research to “Hold” https://t.co/Sb8fas6SFU January 15th 2020, 12:01pm |
|
@newsfilterio BioLineRx Receives Orphan Drug Designation for Motixafortide for the Treatment of Pancreatic Cancer in Europe $BLRX https://t.co/kVV5OtIKvW January 15th 2020, 3:01am |
 |
@EnterpriseLeade Zacks Investment Research Upgrades BIOLINERX LTD/S $BLRX to “Strong-Buy” https://t.co/P0UkaMFR7V January 15th 2020, 3:01am |
|
@newsfilterio BioLineRx's Motixafortide an Orphan drug in Europe; shares up 7% premarket $BLRX https://t.co/V7yu1qRAQP January 15th 2020, 12:01am |
|
@MaisaCorp $MRK $BLRX the European Commission has granted orphan drug designation to its lead oncology candidate Motixafortide… https://t.co/qKwklz0myg January 14th 2020, 6:01pm |
 |
@Badboysmarket $BLRX $3 test this week? 2.48 +3.77 flirting with the 50ma January 14th 2020, 2:01pm |
|
@marketdollqueen $BLRX made my day trade alert list premarket this morning...open house all week with my link January 14th 2020, 1:01pm |
|
@Badboysmarket $BLRX 2.40 barely green move January 14th 2020, 12:01pm |
|
@StockNewsNow $BLRX BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment of Pancreatic Cancer… https://t.co/XBuhjplgkC January 14th 2020, 12:01pm |
|
@noobdotcom RT @odibro: $BLRX ODD for Motixafortide (BL-8040) for the Treatment of Pancreatic Cancer in Europe January 14th 2020, 11:01am |
 |
@7LadyQ $BLRX BioLineRx's Motixafortide an Orphan drug in Europe; shares up 7% premarket BioLineRx (NASDAQ:BLRX) is up 7% p… https://t.co/kz4zWNlVI3 January 14th 2020, 8:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.